INCYTE CORP(NASDAQ:INCY) stock News

INCY Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill - Mentions: MOS SJM EW ICE ...

Which S&P500 stocks are gapping on Wednesday?

19 hours ago - By: Benzinga

What 14 Analyst Ratings Have To Say About Incyte

2 days ago - By: Incyte

Incyte to Report Third Quarter Financial Results

10 days ago - By: Zacks Investment Research - Mentions: ARGX

INCY vs. ARGX: Which Stock Is the Better Value Option?

16 days ago - By: Incyte

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 days ago - By: Incyte

Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer

21 days ago - By: Benzinga

Incyte Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)

22 days ago - By: Incyte

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

23 days ago - By: Zacks Investment Research - Mentions: NVS ANIP CRMD

INCY Announces New Late-Stage Data on Skin Disease Drug

23 days ago - By: Incyte

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025

a month ago - By: Incyte

Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress

a month ago - By: Zacks Investment Research - Mentions: TGTX

Why Is TG Therapeutics (TGTX) Up 4.7% Since Last Earnings Report?

a month ago - By: Incyte

Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa

a month ago - By: Zacks Investment Research

Incyte (INCY) Up 9.4% Since Last Earnings Report: Can It Continue?

a month ago - By: Yahoo Finance

Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN Partnership

a month ago - By: Incyte

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Incyte

Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer

2 months ago - By: Zacks Investment Research - Mentions: PFE LLY ABBV

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

2 months ago - By: Zacks Investment Research - Mentions: NVS QGEN

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

2 months ago - By: Yahoo Finance

INCYTE CORP (INCY) Stock News

INCY Latest News, Press Relases and Analysis

Which S&P500 stocks are gapping on Wednesday?

What 14 Analyst Ratings Have To Say About Incyte

Incyte to Report Third Quarter Financial Results

INCY vs. ARGX: Which Stock Is the Better Value Option?

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer

Incyte Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

INCY Announces New Late-Stage Data on Skin Disease Drug

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025

Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress

Why Is TG Therapeutics (TGTX) Up 4.7% Since Last Earnings Report?

Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa

Incyte (INCY) Up 9.4% Since Last Earnings Report: Can It Continue?

Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN Partnership

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

Are Wall Street Analysts Predicting Incyte Stock Will Climb or Sink?